Antineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantCombined Modality TherapyAntineoplastic AgentsNeoplasm, ResidualCisplatinTreatment OutcomeNeoplasmsCyclophosphamideDoxorubicinNeoplasm StagingLung NeoplasmsPancreatic NeoplasmsBreast NeoplasmsNeoadjuvant TherapyDisease-Free SurvivalPrognosisSurvival AnalysisEtoposideSurvival RateNeoplasm Recurrence, LocalOvarian NeoplasmsDrug Administration ScheduleTesticular NeoplasmsMethotrexateNeoplasms, Cystic, Mucinous, and SerousCarboplatinPaclitaxelLiver NeoplasmsVinblastineFollow-Up StudiesInduction ChemotherapyNeoplasms, Second PrimaryNeoplasm MetastasisDrug Resistance, NeoplasmSkin NeoplasmsAdenocarcinomaNeoplasms, Multiple PrimaryTaxoidsNeoplasms, Germ Cell and EmbryonalColorectal NeoplasmsBone NeoplasmsIfosfamideTime FactorsBleomycinTumor Markers, BiologicalAntimetabolites, AntineoplasticDeoxycytidineOrganoplatinum CompoundsLymphomaKidney NeoplasmsLymphoma, Non-HodgkinHodgkin DiseaseAntineoplastic Agents, AlkylatingImmunohistochemistryAnthracyclinesCytarabineStomach NeoplasmsChemotherapy, Cancer, Regional PerfusionSalvage TherapyPeritoneal NeoplasmsAdenocarcinoma, MucinousCarcinomaProspective StudiesCarcinoma, Non-Small-Cell LungNeoplasms, Glandular and EpithelialRadiotherapyTransplantation, AutologousRadiotherapy, AdjuvantDNA, NeoplasmSoft Tissue NeoplasmsNeutropeniaColonic NeoplasmsVomitingMediastinal NeoplasmsThyroid NeoplasmsAntineoplastic Agents, PhytogenicRecurrenceGastrointestinal NeoplasmsNauseaTomography, X-Ray ComputedKaplan-Meier EstimateClinical Trials as TopicAntibiotics, AntineoplasticPrecursor Cell Lymphoblastic Leukemia-LymphomaDacarbazineCarcinoma, Squamous CellOsteosarcomaNeoplasm ProteinsMyeloproliferative DisordersLymphatic MetastasisAppendiceal NeoplasmsCarmustineHead and Neck NeoplasmsSarcomaDose-Response Relationship, DrugNeoplasms, ExperimentalNeoplasm InvasivenessCell Line, TumorDisease Progression